Topal, Alper, and Mustafa Başak. 2025. “Evaluating the Role of HER2-Low Versus HER2-0 Status in Predicting Response to Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer”. The European Research Journal 11 (5): 858-67. https://doi.org/10.18621/eurj.1704067.